Inhibition/NN
of/IN
T/NN
lymphocyte/NN
activation/NN
by/IN
cAMP/NN
is/VBZ
associated/VBN
with/IN
down-regulation/NN
of/IN
two/CD
parallel/JJ
mitogen-activated/JJ
protein/NN
kinase/NN
pathways/NNS
,/,
the/DT
extracellular/JJ
signal-related/JJ
kinase/NN
and/CC
c-Jun/NN
N-terminal/JJ
kinase/NN
./.

The/DT
induction/NN
of/IN
T/NN
cell/NN
proliferation/NN
requires/VBZ
signals/NNS
from/IN
the/DT
TCR/NN
and/CC
a/DT
co-receptor/NN
molecule/NN
,/,
such/JJ
as/IN
CD28/NN
,/,
that/WDT
activate/VBP
parallel/JJ
and/CC
partially/RB
cross-reactive/JJ
signaling/NN
pathways/NNS
./.
=====
These/DT
pathways/NNS
are/VBP
disrupted/VBN
by/IN
agonists/NNS
that/WDT
utilize/VBP
adenylate/NN
cyclase/NN
and/CC
cAMP-dependent/JJ
protein/NN
kinase/NN
A/NN
(/(
PKA/NN
)/)
./.
=====
We/PRP
found/VBD
that/IN
the/DT
adenylate/NN
cyclase/NN
activator/NN
,/,
forskolin/NN
,/,
inhibits/VBZ
anti-CD3-induced/JJ
shift/NN
in/IN
Lck/NN
electrophoretic/JJ
mobility/NN
,/,
suggesting/VBG
an/DT
intervention/NN
at/IN
the/DT
TCR-coupled/JJ
phosphoinositide/JJ
turnover/NN
that/WDT
precedes/VBZ
the/DT
activation/NN
of/IN
PKC/NN
./.
=====
The/DT
shift/NN
of/IN
Lck/NN
following/VBG
direct/JJ
PKC/NN
activation/NN
by/IN
12-O-tetradecanoyl/NN
phorbol/NN
13-acetate/NN
,/,
which/WDT
bypasses/VBZ
early/JJ
receptor-triggered/JJ
biochemical/JJ
events/NNS
,/,
is/VBZ
insensitive/JJ
to/TO
forskolin/NN
./.
=====
Nevertheless/RB
,/,
forskolin/NN
also/RB
inhibits/VBZ
PKC/NN
downstream/JJ
events/NNS
,/,
such/JJ
as/IN
c-jun/NN
expression/NN
,/,
which/WDT
is/VBZ
critical/JJ
for/IN
the/DT
activation/NN
process/NN
of/IN
T/NN
cells/NNS
./.
=====
To/TO
further/RB
analyze/VB
potential/JJ
cross/NN
points/NNS
between/IN
positively/RB
and/CC
negatively/RB
regulating/VBG
signaling/NN
pathways/NNS
in/IN
T/NN
cells/NNS
,/,
we/PRP
tested/VBD
the/DT
effects/NNS
of/IN
activators/NNS
of/IN
the/DT
adenylate/NN
cyclase/NN
or/CC
PKA/NN
on/IN
two/CD
parallel/JJ
mitogen-activated/JJ
protein/NN
kinase/NN
signaling/NN
pathways/NNS
mediated/VBN
by/IN
extracellular/JJ
signal-regulated/JJ
kinase/NN
(/(
ERK/NN
)/)
and/CC
c-Jun/NN
N-terminal/JJ
kinase/NN
./.
=====
Using/VBG
a/DT
PKC-specific/JJ
inhibitor/NN
,/,
GF109203X/NN
,/,
or/CC
PKC-depleted/JJ
T/NN
cells/NNS
,/,
we/PRP
found/VBD
that/IN
a/DT
large/JJ
part/NN
of/IN
the/DT
anti-CD3-induced/JJ
ERK/NN
activation/NN
is/VBZ
PKC/NN
dependent/JJ
./.
=====
Both/CC
PKC-dependent/JJ
and/CC
-independent/JJ
activation/NN
of/IN
ERK/NN
were/VBD
sensitive/JJ
to/TO
inhibition/NN
by/IN
forskolin/NN
or/CC
a/DT
cell-permeable/JJ
cAMP/NN
analogue/NN
,/,
dbcAMP/NN
./.
=====
Furthermore/RB
,/,
the/DT
effect/NN
of/IN
12-O-tetradecanoyl/NN
phorbol/NN
13-acetate/NN
and/CC
ionomycin/NN
,/,
which/WDT
synergized/VBD
to/TO
fully/RB
activate/VB
c-Jun/NN
N-terminal/JJ
kinase/NN
,/,
was/VBD
also/RB
sensitive/JJ
to/TO
inhibition/NN
by/IN
forskolin/NN
./.
=====
Our/PRP$
results/NNS
suggest/VBP
that/IN
PKA/NN
inhibits/VBZ
T/NN
cell/NN
activation/NN
by/IN
interfering/VBG
with/IN
multiple/JJ
events/NNS
along/IN
the/DT
two/CD
signaling/NN
pathways/NNS
operating/VBG
downstream/RB
of/IN
the/DT
TCR/NN
and/CC
the/DT
CD28/NN
co-receptor/NN
molecules/NNS
./.